Skip to main content

A $14,000 cholesterol drug gets a price cut as Regeneron, Sanofi strike deal with Express Scripts

Praluent's new price will be between $4,500 and $8,000 per year, which is the range recommended in March by the Institute for Clinical and Economic Review.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.